GOSS — GOSSAMER BIO INC

Ownership history in DLD Asset Management, LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which DLD Asset Management, LP reported a position in GOSSAMER BIO INC (GOSS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2019 Q3)
Avg. % of fund
0.07%
First filed
2019 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 37,543 -139,257 -78.8% 0.01% $99K $2.63
2025 Q3 ADDED 176,800 +117,200 +196.6% 0.03% $464K $2.63
2025 Q2 REDUCED 59,600 -42,400 -41.6% 0.01% $73K $1.23
2019 Q3 REDUCED 102,000 -156,600 -60.6% 0.09% $1.7M $16.79
2019 Q3 INITIATED 258,600 — — 0.22% $4.3M $16.79
% of Fund (quarterly)    GOSS price (monthly, adj. close)

Other funds also holding GOSS

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 5.24% ARCH Venture Management, LLC 3Y 7Y 3.83% NEA Management Company, LLC 3Y 7Y 2.86% MB Generational Wealth, LLC 2.63% Samsara BioCapital, LLC 3Y 7Y 2.31% Palo Alto Investors LP 3Y 7Y 1.93% Monashee Investment Management LLC 3Y 7Y 1.75% Opaleye Management Inc. 3Y 7Y 1.11% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.92% 683 Capital Management, LLC 3Y 7Y 0.7%
← Back to DLD Asset Management, LP Holdings